How is the R&D Department of Yantai Haoyuan Biomedical Technology Co., Ltd.

The R&D Department of Yantai Haoyuan Biomedical Technology Co., Ltd. is good. According to relevant information inquiries, the company has a good environment, good treatment, high wages, a better R&D department, no overtime, and weekend breaks. Yantai Haoyuan Biomedical Technology Co., Ltd. was founded in 2021. It is a wholly-owned subsidiary of Shanghai Haoyuan Pharmaceutical Co., Ltd. (stock code: 688131). It focuses on the research and development of molecular building blocks and tool compounds in the field of small molecule drug discovery. As well as process development and production technology improvement of small molecule drug APIs and intermediates, it is a high-tech company that provides related products and technical services from drug discovery to large-scale production of APIs and pharmaceutical intermediates to global pharmaceutical companies and scientific research institutions. enterprise.